Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:FAR NASDAQ:KOD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFARForaco InternationalC$1.89-0.5%C$1.81C$1.57▼C$2.55C$132.63M1.2582,959 shs6,100 shsKODKodiak Sciences$9.48-15.7%$5.72$1.92▼$11.60$500.73M2.41442,992 shs923,590 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFARForaco International0.00%+3.83%+5.56%+2.70%-19.83%KODKodiak Sciences+6.43%+40.10%+103.80%+177.09%+355.47%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFARForaco International1.1483 of 5 stars2.00.00.80.00.61.71.3KODKodiak Sciences3.1593 of 5 stars2.01.00.04.62.53.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFARForaco International 0.00N/AC$4.25124.87% UpsideKODKodiak Sciences 2.00Hold$11.7523.95% UpsideCurrent Analyst Ratings BreakdownLatest 1SN, KOD, CUSN, and FAR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025KODKodiak SciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $5.008/14/2025KODKodiak SciencesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$4.00 ➝ $7.008/14/2025KODKodiak SciencesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Neutral$15.00(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFARForaco InternationalC$227.57M0.58C$0.34 per share5.54C$0.96 per share1.98KODKodiak SciencesN/AN/AN/AN/A$2.86 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFARForaco InternationalC$19.15MC$0.384.91∞N/A8.42%31.54%13.19%N/AKODKodiak Sciences-$176.21M-$3.80N/AN/AN/AN/A-155.27%-63.29%N/ALatest 1SN, KOD, CUSN, and FAR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025KODKodiak Sciences-$1.01-$1.03-$0.02-$1.03N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFARForaco InternationalN/A2.52%N/AN/AN/AKODKodiak SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFARForaco International115.591.430.88KODKodiak SciencesN/A3.483.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFARForaco International5.03%KODKodiak Sciences89.06%Insider OwnershipCompanyInsider OwnershipFARForaco International35.74%KODKodiak Sciences45.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFARForaco International1,00070.17 millionN/ANot OptionableKODKodiak Sciences9052.82 million28.58 millionOptionable1SN, KOD, CUSN, and FAR HeadlinesRecent News About These CompaniesKodiak Sciences to Present at American Chemical Society Fall 20255 hours ago | prnewswire.comKodiak Sciences (NASDAQ:KOD) Shares Up 8.4% - Here's WhyAugust 17 at 3:00 PM | marketbeat.comKodiak Sciences (NASDAQ:KOD) Stock Rating Upgraded by JPMorgan Chase & Co.August 17 at 3:31 AM | americanbankingnews.comKodiak Sciences (NASDAQ:KOD) Shares Gap Up - Time to Buy?August 16 at 12:09 PM | marketbeat.comKodiak Sciences (NASDAQ:KOD) Rating Increased to Neutral at JPMorgan Chase & Co.August 16 at 8:21 AM | marketbeat.comXTX Topco Ltd Acquires New Stake in Kodiak Sciences Inc. (NASDAQ:KOD)August 16 at 3:18 AM | marketbeat.comJP Morgan Upgrades Kodiak Sciences (KOD)August 15, 2025 | msn.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial ResultsAugust 14, 2025 | finanznachrichten.deKodiak Sciences price target raised to $7 from $4 at BarclaysAugust 14, 2025 | msn.comKodiak Q2 Loss Wider Than Expected, Pipeline Development in FocusAugust 14, 2025 | zacks.comKodiak Sciences Reports Q2 2025 Financial Results and Clinical ProgressAugust 14, 2025 | msn.comKodiak Sciences reports Q2 EPS ($1.03), consensus ($1.05)August 13, 2025 | msn.comKodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comFederated Hermes Inc. Acquires Shares of 84,006 Kodiak Sciences Inc. (NASDAQ:KOD)August 11, 2025 | marketbeat.comKodiak Sciences (KOD) to Release Quarterly Earnings on WednesdayAugust 11, 2025 | americanbankingnews.comKodiak Sciences (KOD) to Release Earnings on WednesdayAugust 6, 2025 | marketbeat.comKodiak Sciences Inc. (NASDAQ:KOD) Shares Bought by GSA Capital Partners LLPAugust 4, 2025 | marketbeat.comKodiak Sciences Inc. (KOD) Stock Price Today - WSJJuly 25, 2025 | wsj.comTsunami alerts for Alaska canceled after 7.3-magnitude earthquake off AleutiansJuly 18, 2025 | msn.comPart 1: Johnson recounts PTSD treatment after May breakdownJuly 17, 2025 | kodiakdailymirror.comKEnduring the heat of CaliforniaJuly 15, 2025 | kodiakdailymirror.comKNew MarketBeat Followers Over TimeMedia Sentiment Over Time1SN, KOD, CUSN, and FAR Company DescriptionsForaco International TSE:FARC$1.89 -0.01 (-0.53%) As of 04:00 PM EasternForaco International SA is the business of providing mineral and water drilling services and hydraulic drilling. It specializes in drilling in harsh environments and isolated locations including desert, and mountainous regions. The principal sources of revenue consist of drilling contracts for companies involved in mining and water exploration. The group has its operations in Europe, the Middle East and Africa, North America, South America and the Asia Pacific.Kodiak Sciences NASDAQ:KOD$9.48 -1.77 (-15.73%) Closing price 04:00 PM EasternExtended Trading$9.28 -0.20 (-2.11%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Home Depot Holds Gains After Narrow Q2 Misses Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? D-Wave Buying Spree: Will These Firms Be Potential Targets? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Can AI Defense Contracts Push Palantir Shares Higher? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access